The effect of gold treatment on monocyte interleukin-1 production in rheumatoid arthritis. A prospective study (Q68634126)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

title

The effect of gold treatment on monocyte interleukin-1 production in rheumatoid arthritis. A prospective study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference

V A Danis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

A J Kulesz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

D E Kelly

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

D S Nelson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

P M Brooks

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

Rheumatology International

26 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

page(s)

153-158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

1958 Revision of diagnostic criteria for rheumatoid arthritis

26 September 2019

cites work

1 reference

12 December 2020

Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study

1 reference

12 December 2020

Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor

1 reference

12 December 2020

Can 'disease modifying' drugs influence outcome in rheumatoid arthritis?

1 reference

12 December 2020

The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales

1 reference

12 December 2020

Low density lymphocytes: their relationship to disease activity and to antirheumatic therapy

1 reference

12 December 2020

The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis

1 reference

12 December 2020

Interleukin 1 activity produced by human rheumatoid and normal dendritic cells.

1 reference

12 December 2020

Interleukin-1 secretion by peripheral blood monocytes and synovial macrophages from patients with rheumatoid arthritis

1 reference

12 December 2020

Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis

1 reference

12 December 2020

Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences.

1 reference

12 December 2020

Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha

1 reference

12 December 2020

One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo

1 reference

12 December 2020

Multiple cytokine activities and loss of interleukin 2 inhibitor in synovial fluids of patients with rheumatoid arthritis

1 reference

12 December 2020

The history of gold therapy in rheumatoid disease

1 reference

12 December 2020

Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study

1 reference

12 December 2020

Unique properties of auranofin as a potential anti-rheumatic drug

1 reference

12 December 2020

Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis

1 reference

12 December 2020

Role of HLA class II and cytokine expression in rheumatoid arthritis

1 reference

12 December 2020

Species-specificity of T cell stimulating activities of IL 2 and BSF-1 (IL 4): comparison of normal and recombinant, mouse and human IL 2 and BSF-1 (IL 4)

1 reference

12 December 2020

Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level

1 reference

12 December 2020

Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture

1 reference

12 December 2020

Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes

1 reference

12 December 2020

Longterm results of auranofin therapy

1 reference

12 December 2020

Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction

1 reference

12 December 2020

Changes in immune function in patients with rheumatoid arthritis following treatment with sodium aurothiomalate.

1 reference

12 December 2020

Risk factors that may influence development of side effects of gold sodium thiomalate

1 reference

12 December 2020

Effects of gold on the production of and response to human interleukin-1.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02274840

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2259840%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference